Skip to Content
Merck
  • Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.

Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.

Journal of medicinal chemistry (2005-09-02)
Markus A Lill, Fabienne Winiger, Angelo Vedani, Beat Ernst
ABSTRACT

We investigated the influence of induced fit of the androgen receptor binding pocket on free energies of ligand binding. On the basis of a novel alignment procedure using flexible docking, molecular dynamics simulations, and linear-interaction energy analysis, we simulated the binding of 119 molecules representing six compound classes. The superposition of the ligand molecules emerging from the combined protocol served as input for Raptor, a receptor-modeling tool based on multidimensional QSAR allowing for ligand-dependent induced fit. Throughout our study, protein flexibility was explicitly accounted for. The model converged at a cross-validated r(2) = 0.858 (88 training compounds) and yielded a predictive r(2) = 0.792 (26 test compounds), thereby predicting the binding affinity of all compounds close to their experimental value. We then challenged the model by testing five molecules not belonging to compound classes used to train the model: the IC(50) values were predicted within a factor of 4.5 compared to the experimental data. The demonstrated predictivity of the model suggests that our approach may well be beneficial for both drug discovery and the screening of environmental chemicals for endocrine-disrupting effects, a problem that has recently become a cause for concern among scientists, environmental advocates, and politicians alike.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-(Benzyloxy)phenol, 98%
Supelco
Prednisolone, VETRANAL®, analytical standard
Sigma-Aldrich
Coumestrol, ≥95.0% (HPLC)
Sigma-Aldrich
17α-Methyltestosterone, ≥97.0% (HPLC)
Supelco
2,4′-DDT solution, 100 μg/mL in methanol, PESTANAL®, analytical standard
Sigma-Aldrich
Cholesterol, tested according to Ph. Eur.
Sigma-Aldrich
Diphenylmethane, 99%
Supelco
Progesterone, VETRANAL®, analytical standard
Sigma-Aldrich
4-Chloro-2-methylphenol, 97%
Supelco
Methyl Paraben, PESTANAL®, analytical standard
Sigma-Aldrich
Vanillin, ≥97%, FCC, FG
Sigma-Aldrich
4-tert-Butylphenol, 99%
Sigma-Aldrich
Vanillin, ReagentPlus®, 99%
Sigma-Aldrich
4-Dodecylphenol, mixture of isomers
Supelco
4-Chloro-2-methylphenol, PESTANAL®, analytical standard
Supelco
Testosterone, VETRANAL®, analytical standard
Sigma-Aldrich
Vanillin, tested according to Ph. Eur.
Sigma-Aldrich
Corticosterone, ≥98.5% (HPLC)
Sigma-Aldrich
4-Octylphenol, 99%
Sigma-Aldrich
2,4-Dihydroxybenzophenone, 99%
Sigma-Aldrich
4-Phenylphenol, purified by sublimation, 99%
Supelco
4,4′-DDE, PESTANAL®, analytical standard
Sigma-Aldrich
4-Phenylphenol, 97%
Supelco
4,4′-DDT, PESTANAL®, analytical standard
Supelco
Androsterone, VETRANAL®, analytical standard
Sigma-Aldrich
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Hydrocortisone-Water Soluble, BioReagent, suitable for cell culture
Sigma-Aldrich
Genistein, synthetic, ≥98% (HPLC), powder
Sigma-Aldrich
17α-Ethynylestradiol, ≥98%
Sigma-Aldrich
19-Norethindrone, ≥98%, powder